OBJECTIVE: To identify factors associated with in-hospital outcome of adult patients admitted to the ICU with infective endocarditis (IE). DESIGN AND SETTING: Retrospective study performed in the two medical ICUs of a teaching hospital. PATIENTS AND PARTICIPANTS: The charts of all 228 consecutive patients aged 18 years or older admitted with infective IE between January 1993 and December 2000 were reviewed. All patients satisfied the modified Duke's criteria for definite IE. MEASUREMENTS AND RESULTS: There were 146 episodes of native valve endocarditis and 82 of prosthetic valve endocarditis. Staphylococcus aureus was the predominant causative micro-organism. Most complications occurred early during the course of IE. One-half of the patients underwent cardiac surgery during the same hospitalization and had a better outcome than nonoperated patients. The overall in-hospital mortality rate was 45% (102/228). Multivariate analysis revealed the following clinical factors in patients with native valve IE as independently associated with outcome: septic shock (odds ratio 4.81), cerebral emboli (3.00), immunocompromised state (2.88), and cardiac surgery (0.475); in patients with prosthetic valve IE the factors were: septic shock (4.07), neurological complications (3.1), and immunocompromised state (3.46). CONCLUSIONS: IE still carries high morbidity and mortality rates for the subset of patients requiring ICU admission. Most complications occur early making the decision process for optimal medical and surgical management more difficult. Surgical treatment appears to improve in-hospital outcome.
OBJECTIVE: To identify factors associated with in-hospital outcome of adult patients admitted to the ICU with infective endocarditis (IE). DESIGN AND SETTING: Retrospective study performed in the two medical ICUs of a teaching hospital. PATIENTS AND PARTICIPANTS: The charts of all 228 consecutive patients aged 18 years or older admitted with infective IE between January 1993 and December 2000 were reviewed. All patients satisfied the modified Duke's criteria for definite IE. MEASUREMENTS AND RESULTS: There were 146 episodes of native valve endocarditis and 82 of prosthetic valve endocarditis. Staphylococcus aureus was the predominant causative micro-organism. Most complications occurred early during the course of IE. One-half of the patients underwent cardiac surgery during the same hospitalization and had a better outcome than nonoperated patients. The overall in-hospital mortality rate was 45% (102/228). Multivariate analysis revealed the following clinical factors in patients with native valve IE as independently associated with outcome: septic shock (odds ratio 4.81), cerebral emboli (3.00), immunocompromised state (2.88), and cardiac surgery (0.475); in patients with prosthetic valve IE the factors were: septic shock (4.07), neurological complications (3.1), and immunocompromised state (3.46). CONCLUSIONS: IE still carries high morbidity and mortality rates for the subset of patients requiring ICU admission. Most complications occur early making the decision process for optimal medical and surgical management more difficult. Surgical treatment appears to improve in-hospital outcome.
Authors: J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey Journal: Clin Infect Dis Date: 2000-04-03 Impact factor: 9.079
Authors: Isidre Vilacosta; Catherine Graupner; José Alberto San Román; Cristina Sarriá; Ricardo Ronderos; Cristina Fernández; Leonardo Mancini; Olga Sanz; Juan Victor Sanmartín; Walter Stoermann Journal: J Am Coll Cardiol Date: 2002-05-01 Impact factor: 24.094
Authors: G Di Salvo; G Habib; V Pergola; J F Avierinos; E Philip; J P Casalta; J M Vailloud; G Derumeaux; J Gouvernet; P Ambrosi; M Lambert; A Ferracci; D Raoult; R Luccioni Journal: J Am Coll Cardiol Date: 2001-03-15 Impact factor: 24.094
Authors: Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Tahaniyat Lalani; Christopher H Cabell; Daniel K Benjamin; Ovidiu Lasca; Christoph Naber; Vance G Fowler; G Ralph Corey; Vivian H Chu; Michael Fenely; Orathai Pachirat; Ru-San Tan; Richard Watkin; Adina Ionac; Asuncion Moreno; Carlos A Mestres; José Casabé; Natalia Chipigina; Damon P Eisen; Denis Spelman; Francois Delahaye; Gail Peterson; Lars Olaison; Andrew Wang Journal: Circulation Date: 2010-02-16 Impact factor: 29.690
Authors: Juan Gálvez-Acebal; Jesús Rodríguez-Baño; Francisco J Martínez-Marcos; Jose M Reguera; Antonio Plata; Josefa Ruiz; Manuel Marquez; Jose M Lomas; Javier de la Torre-Lima; Carmen Hidalgo-Tenorio; Arístides de Alarcón Journal: BMC Infect Dis Date: 2010-01-22 Impact factor: 3.090